Custom Protein Expression
Functional Protein, 95% Purity
Fast turnaround (2-3 weeks)
1-10 mg from E. Coli expression
for only $1790
No outsourcing to China or India


in vitro Protein Synthesis
Full-length protein in 1 week
95% Purity, From any gene
(toxic or membrane proteins)
Isotopic Labelling for NMR

50 µg~3 mg, $390 to $2500
Excellgen

Osteoporosis And Bone Augmentation/Implant Outcomes: An Observational Study

Martin A Freilich
Reconstructive Sciencesuniversity Of Connecticut Sch Of Med/dnt

Grant 5R01DE017873-04 from National Institute Of Dental & Craniofacial Research IRG: ZDE1

Abstract: Osteoporosis is a major public health issue in our aging population, affecting 44 million Americans. Evidence in the literature suggests that bone disorders such as osteoporosis, may compromise bone augmentation procedure outcomes. It is important, therefore, to better understand the relationship between this disorder and bone augmentation/dental implantation. The objective of this descriptive "best clinical practice" based study is to collect descriptive data estimating alveolar bone augmentation/implant placement success in postmenopausal women with bone mineral density (BMD) ranging from normal to osteoporotic. This is a critical first step in understanding this potentially important relationship. These data are needed to support the future development of bone biology founded hypotheses that will investigate potential associations of specific measures of bone health, including history of osteoporosis, with the successful integration of new bone from bone augmentation procedures. Our multidisciplinary group possesses expertise in epidemiology, behavioral science, radiography, implant surgery, prosthodontics, endocrinology/bone biology and clinical treatment of osteoporosis. We plan to accomplish the objectives of this application by pursuing two specific aims 1) To generate a descriptive estimate of the two-year success rate of bone augmentation followed by dental implant placement in postmenopausal women with normal to osteoporotic bone density; and 2) To explore potential associations between bone health parameters (e.g., BMD, biochemical markers of bone turnover, fracture history and vitamin D levels) and implant failure. To satisfy both aims, 120 subjects will receive bone augmentation, implant placement and prosthetic treatment based upon their specific presenting clinical situation, as guided by a specific set of criteria that will be part of the study protocol. Implant survival will be the primary outcome measure of success. However, success will be secondarily assessed by other relevant clinical outcomes, clinical efficiency, as well as patient satisfaction, pain and quality of life. Descriptive analyses will also explore potential predictive associations between bone health parameters and bone augmentation/implant success, both individually and in conjunction with one another. Data from this study will provide information about differential implant success rates for women possessing a spectrum of bone mineral density. Our long-range goal is to identify the most important predictors of bone augmentation/implant placement success among patients with compromised bone health and/or unfavorable local alveolar architecture. We then wish to develop and test the best methods by which to provide these therapies, including the application of techniques with which to guide new alveolar bone formation at deficient osseous sites. This application represents an important step in this ongoing research initiative

Project start date: 2006-09-15

Project end date: 2011-06-30


Sponsored Links Excellgen http://Excellgen.com

Functional Recombinant Proteins by in vitro Protein Synthesis, 3 days, 95% Purity
Full-length, high quality protein, high yield, high throughput, any genes (toxic, low GC content), membrane proteins, isotopic labelling. $598, $398
Protein expression & purification: E. Coli, insect and mammalian cells
Fast turn around, 3 mg of >95% purity functional protein. No outsourcing to China or India. $2500, $1800
GeneExpresso DNA Transfection Reagent
Low Cytotoxicity, Higher Transfection Efficiency than Lipofectamine 2000. $188, $138

Osteoporosis And Bone Augmentation/Implant Outcomes: An Observational Study

Martin A Freilich
Reconstructive Sciencesuniversity Of Connecticut Sch Of Med/dnt
office Of Research & Sponsored Programs
farmington, Ct 06030

Grant 5R01DE017873-03 from National Institute Of Dental & Craniofacial Research IRG: ZDE1

Abstract: Osteoporosis is a major public health issue in our aging population, affecting 44 million Americans. Evidence in the literature suggests that bone disorders such as osteoporosis, may compromise bone augmentation procedure outcomes. It is important, therefore, to better understand the relationship between this disorder and bone augmentation/dental implantation. The objective of this descriptive "best clinical practice" based study is to collect descriptive data estimating alveolar bone augmentation/implant placement success in postmenopausal women with bone mineral density (BMD) ranging from normal to osteoporotic. This is a critical first step in understanding this potentially important relationship. These data are needed to support the future development of bone biology founded hypotheses that will investigate potential associations of specific measures of bone health, including history of osteoporosis, with the successful integration of new bone from bone augmentation procedures. Our multidisciplinary group possesses expertise in epidemiology, behavioral science, radiography, implant surgery, prosthodontics, endocrinology/bone biology and clinical treatment of osteoporosis. We plan to accomplish the objectives of this application by pursuing two specific aims 1) To generate a descriptive estimate of the two-year success rate of bone augmentation followed by dental implant placement in postmenopausal women with normal to osteoporotic bone density; and 2) To explore potential associations between bone health parameters (e.g., BMD, biochemical markers of bone turnover, fracture history and vitamin D levels) and implant failure. To satisfy both aims, 120 subjects will receive bone augmentation, implant placement and prosthetic treatment based upon their specific presenting clinical situation, as guided by a specific set of criteria that will be part of the study protocol. Implant survival will be the primary outcome measure of success. However, success will be secondarily assessed by other relevant clinical outcomes, clinical efficiency, as well as patient satisfaction, pain and quality of life. Descriptive analyses will also explore potential predictive associations between bone health parameters and bone augmentation/implant success, both individually and in conjunction with one another. Data from this study will provide information about differential implant success rates for women possessing a spectrum of bone mineral density. Our long-range goal is to identify the most important predictors of bone augmentation/implant placement success among patients with compromised bone health and/or unfavorable local alveolar architecture. We then wish to develop and test the best methods by which to provide these therapies, including the application of techniques with which to guide new alveolar bone formation at deficient osseous sites. This application represents an important step in this ongoing research initiative

Keywords: bone, implant, osteoporosis X ray, aging, base, biology, bone density, bone development, bone disorder, bone fracture, bone metabolism, choice, density, dental implant, diagnosis, emotion, endocrinology, epidemiology, experience, fasting, gold, health, health /scientific organization, hip, insight, jaw, literature survey, measurement, mineral, model, orthodontic appliance, osteogenesis, pain, public health, quality of life, radiography, role, satisfaction, sectioning, spine, statistics /biometry, success, surgery, therapy, tooth loss, vitamin, vitamin D clinical research

Project start date: 2006-09-15

Project end date: 2011-06-30

5R01DE017873-03 (2008): $599520


5R01DE017873-02 (2007): $537235


Grants awarded to Martin A Freilich

Evaluation Of Fiber Biomaterials For Oral Implantology

Martin A Freilich
Reconstructive Sciencesuniversity Of Connecticut Sch Of Med/dnt
263 Farmington Avenue
farmington, Ct 060302806

Grant 1K23DE014187-01 from National Institute Of Dental & Craniofacial Research IRG: DSR

Abstract: This application for a K23 award is based upon this candidate´s tong-term goal to design and conduct clinical research and develop new dental biomaterials for clinical use. The candidate is board qualified in two clinical dental specialties, Prosthodontics and Periodontics. As a resident and faculty member, he has had opportunities to work with knowledgeable researchers who have guided his efforts in patient-based research. The candidate has developed a good understanding of scientific method and a solid foundation of skills, but seeks to further his research skills to gain independence and more effectively collaborate with biomaterials researchers and biostatisticians. A mentored training program which includes specific areas of didactic training in areas such as clinical research methodology, data management, biostatistics and polymer composite science will allow the candidate to accomplish these goals. The focus of this candidate´s research in recent years has been fiber-reinforced composite (FRC) research. The candidate has been involved in developing FRC materials, devising techniques for their use in making dental prostheses and testing these materials and techniques in the laboratory and the clinic. This proposal is designed to provide a clinics test for FRC prostheses used for implant dentistry. Glass FRC materials have been developed which have the potential to make an esthetic dental implant prosthesis substructure without the potential for corrosion and toxicity which may be seen with commonly used metal alloys. Laboratory and clinical research evaluating FRC prostheses used to restore and replace teeth has shown that these materials exhibit excellent mechanical properties and can form a chemical bond to polymer-based veneer materials. Two different designs of FRC implant prostheses have recently been developed 1) Screw-retained, retrievable prostheses and 2) Luted, non-retrievable prostheses. There is an important need for these two designs to be tested to determine if either is clinically superior. The candidate for this K23 award proposes to make an intra subject comparison between these two types of FRC partial implant prosthesis. The primary comparison between these prosthesis designs will be the incidence of Outcomes Requiring Intervention (failure of prosthesis or non-failures requiring intervention) observed over three years of recall examination

Keywords: biomaterial development /preparation, biomaterial evaluation, composite resin, dental implant, dental material, dental prosthesis, patient oriented research clinical trial, human therapy evaluation, oral facial restoration, oral facial restoration material, outcomes research, polymer dental radiography, human subject, medical implant science, statistics /biometry

Project start date: 2001-07-15

Project end date: 2006-05-31

1K23DE014187-01 (2001): $122865


5K23DE014187-05 (2005): $123188

5K23DE014187-04 (2004): $123094

5K23DE014187-03 (2003): $122902

Osteoporosis And Bone Augmentation/Implant Outcomes: An Observational Study

Martin A Freilich
University Of Connecticut Sch Of Med/dnt 263 Farmington Avenue Farmington, Ct 060302806

Grant 1R01DE017873-01 from National Institute Of Dental And Craniofacial Research IRG: ZDE1

Abstract: Osteoporosis is a major public health issue in our aging population, affecting 44 million Americans. Evidence in the literature suggests that bone disorders such as osteoporosis, may compromise bone augmentation procedure outcomes. It is important, therefore, to better understand the relationship between this disorder and bone augmentation/dental implantation. The objective of this descriptive "best clinical practice" based study is to collect descriptive data estimating alveolar bone augmentation/implant placement success in postmenopausal women with bone mineral density (BMD) ranging from normal to osteoporotic. This is a critical first step in understanding this potentially important relationship. These data are needed to support the future development of bone biology founded hypotheses that will investigate potential associations of specific measures of bone health, including history of osteoporosis, with the successful integration of new bone from bone augmentation procedures. Our multidisciplinary group possesses expertise in epidemiology, behavioral science, radiography, implant surgery, prosthodontics, endocrinology/bone biology and clinical treatment of osteoporosis. We plan to accomplish the objectives of this application by pursuing two specific aims 1) To generate a descriptive estimate of the two-year success rate of bone augmentation followed by dental implant placement in postmenopausal women with normal to osteoporotic bone density; and 2) To explore potential associations between bone health parameters (e.g., BMD, biochemical markers of bone turnover, fracture history and vitamin D levels) and implant failure. To satisfy both aims, 120 subjects will receive bone augmentation, implant placement and prosthetic treatment based upon their specific presenting clinical situation, as guided by a specific set of criteria that will be part of the study protocol. Implant survival will be the primary outcome measure of success. However, success will be secondarily assessed by other relevant clinical outcomes, clinical efficiency, as well as patient satisfaction, pain and quality of life. Descriptive analyses will also explore potential predictive associations between bone health parameters and bone augmentation/implant success, both individually and in conjunction with one another. Data from this study will provide information about differential implant success rates for women possessing a spectrum of bone mineral density. Our long-range goal is to identify the most important predictors of bone augmentation/implant placement success among patients with compromised bone health and/or unfavorable local alveolar architecture. We then wish to develop and test the best methods by which to provide these therapies, including the application of techniques with which to guide new alveolar bone formation at deficient osseous sites. This application represents an important step in this ongoing research initiative.

Keywords: bone, implant, osteoporosis, health, success, clinical research

Project start date: 2006-09-15

Project end date: 2011-06-30

1R01DE017873-01 (2006): $562303